Int J Thyroidol.  2021 Nov;14(2):117-126. 10.11106/ijt.2021.14.2.117.

Thyroid and Gut Microbiome

• Kwon SK
• Kim N
• Park YJ

• KMID: 2522916
• DOI: http://doi.org/10.11106/ijt.2021.14.2.117

Abstract

The gut microbiome affects the enterohepatic recycling of thyroid hormone and the metabolism and absorption of micronutrients including iodine and selenium. Changes in thyroid function trigger changes in the neuro-muscular function of the gut, resulting in a two-way interaction that affects the composition of gut microbiome. In recent years, based on animal experiments and prospective clinical studies, many possibilities have been suggested that the influences in naïve immune cells differentiation or increasing permeability of proinflammatory cytokines and endotoxins to blood due to intestinal integrity disruption may affect the progression of autoimmune thyroid disease or thyroid cancers. In this review, we focused on refining the progression on the hypothesis that there is a link between the gut microbiome and the thyroid gland.

Keyword

Microbiome; Microbiota; Thyroid; Autoimmune disease; Thyroid cancer

Figure

• 

  Fig. 1 Bacterial taxonomy classification.

• 

  Fig. 2 Interaction between gut microbiomes and thyroid.

Reference

References

1. Ley RE, Peterson DA, Gordon JI. 2006; Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 124(4):837–48. DOI: 10.1016/j.cell.2006.02.017. PMID: 16497592.

2. Sender R, Fuchs S, Milo R. 2016; Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14(8):e1002533. DOI: 10.1371/journal.pbio.1002533. PMID: 27541692. PMCID: PMC4991899.

3. Vartoukian SR, Palmer RM, Wade WG. 2010; Strategies for culture of 'unculturable' bacteria. FEMS Microbiol Lett. 309(1):1–7. DOI: 10.1111/j.1574-6968.2010.02000.x. PMID: 20487025.

4. Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR. 2004; Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr. 134(2):465–72. DOI: 10.1093/jn/134.2.465. PMID: 14747690.

5. Weinstock GM. 2012; Genomic approaches to studying the human microbiota. Nature. 489(7415):250–6. DOI: 10.1038/nature11553. PMID: 22972298. PMCID: PMC3665339.

6. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. 2006; Metagenomic analysis of the human distal gut microbiome. Science. 312(5778):1355–9. DOI: 10.1126/science.1124234. PMID: 16741115. PMCID: PMC3027896.

7. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. 2010; A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464(7285):59–65. DOI: 10.1038/nature08821. PMID: 20203603. PMCID: PMC3779803.

8. Ko JS. 2013; The intestinal microbiota and human disease. Korean J Gastroenterol. 62(2):85–91. DOI: 10.4166/kjg.2013.62.2.85. PMID: 23981941.

9. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. 2005; Diversity of the human intestinal microbial flora. Science. 308(5728):1635–8. DOI: 10.1126/science.1110591. PMID: 15831718. PMCID: PMC1395357.

10. Iebba V, Totino V, Gagliardi A, Santangelo F, Cacciotti F, Trancassini M, et al. 2016; Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiol. 39(1):1–12. PMID: 26922981.

11. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. 2014; The placenta harbors a unique microbiome. Sci Transl Med. 6(237):237ra65. DOI: 10.1126/scitranslmed.3008599. PMCID: PMC4929217. PMID: 24848255.

12. Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. 2019; What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 7(1):14. DOI: 10.3390/microorganisms7010014. PMID: 30634578. PMCID: PMC6351938.

13. Khosravi A, Mazmanian SK. 2013; Disruption of the gut microbiome as a risk factor for microbial infections. Curr Opin Microbiol. 16(2):221–7. DOI: 10.1016/j.mib.2013.03.009. PMID: 23597788. PMCID: PMC5695238.

14. Schmidt TSB, Raes J, Bork P. 2018; The human gut microbiome: from association to modulation. Cell. 172(6):1198–215. DOI: 10.1016/j.cell.2018.02.044. PMID: 29522742.

15. Kc D, Sumner R, Lippmann S. 2020; Gut microbiota and health. Postgrad Med. 132(3):274. DOI: 10.1080/00325481.2019.1662711. PMID: 31566046.

16. Petersen C, Round JL. 2014; Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 16(7):1024–33. DOI: 10.1111/cmi.12308. PMID: 24798552. PMCID: PMC4143175.

17. Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. 2015; The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 21(8):895–905. DOI: 10.1038/nm.3914. PMID: 26214836.

18. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. 2014; Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy. 44(6):842–50. DOI: 10.1111/cea.12253. PMID: 24330256.

19. Paller AS, Kong HH, Seed P, Naik S, Scharschmidt TC, Gallo RL, et al. 2019; The microbiome in patients with atopic dermatitis. J Allergy Clin Immunol. 143(1):26–35. DOI: 10.1016/j.jaci.2018.11.015. PMID: 30476499. PMCID: PMC7163929.

20. Shahi SK, Freedman SN, Mangalam AK. 2017; Gut microbiome in multiple sclerosis: the players involved and the roles they play. Gut Microbes. 8(6):607–15. DOI: 10.1080/19490976.2017.1349041. PMID: 28696139. PMCID: PMC5730390.

21. Kostic AD, Gevers D, Siljander H, Vatanen T, Hyotylainen T, Hamalainen AM, et al. 2015; The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 17(2):260–73. DOI: 10.1016/j.chom.2015.01.001. PMID: 25662751. PMCID: PMC4689191.

22. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. 2016; The central nervous system and the gut microbiome. Cell. 167(4):915–32. DOI: 10.1016/j.cell.2016.10.027. PMID: 27814521. PMCID: PMC5127403.

23. Ingman WV. 2019; The gut microbiome: a new player in breast cancer metastasis. Cancer Res. 79(14):3539–41. DOI: 10.1158/0008-5472.CAN-19-1698. PMID: 31308136.

24. Hou Y, Sun W, Zhang C, Wang T, Guo X, Wu L, et al. 2017; Meta-analysis of the correlation between Helicobacter pylori infection and autoimmune thyroid diseases. Oncotarget. 8(70):115691–700. DOI: 10.18632/oncotarget.22929. PMID: 29383192. PMCID: PMC5777804.

25. Cellini M, Santaguida MG, Virili C, Capriello S, Brusca N, Gargano L, et al. 2017; Hashimoto's thyroiditis and autoimmune gastritis. Front Endocrinol (Lausanne). 8:92. DOI: 10.3389/fendo.2017.00092. PMID: 28491051. PMCID: PMC5405068.

26. Tudhope GR, Wilson GM. 1960; Anaemia in hypothyroidism. Incidence, pathogenesis, and response to treatment. Q J Med. 29:513–37. PMID: 13778548.

27. Neuman H, Debelius JW, Knight R, Koren O. 2015; Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS Microbiol Rev. 39(4):509–21. DOI: 10.1093/femsre/fuu010. PMID: 25701044.

28. Virili C, Centanni M. 2017; "With a little help from my friends" - The role of microbiota in thyroid hormone metabolism and enterohepatic recycling. Mol Cell Endocrinol. 458:39–43. DOI: 10.1016/j.mce.2017.01.053. PMID: 28167127.

29. Hazenberg MP, de Herder WW, Visser TJ. 1988; Hydrolysis of iodothyronine conjugates by intestinal bacteria. FEMS Microbiol Rev. 4(1):9–16. DOI: 10.1111/j.1574-6968.1988.tb02709.x-i1. PMID: 3078770.

30. Hoefig CS, Wuensch T, Rijntjes E, Lehmphul I, Daniel H, Schweizer U, et al. 2015; Biosynthesis of 3-iodothyronamine from T4 in murine intestinal tissue. Endocrinology. 156(11):4356–64. DOI: 10.1210/en.2014-1499. PMID: 26348473.

31. Meng S, Badrinarain J, Sibley E, Fang R, Hodin R. 2001; Thyroid hormone and the d-type cyclins interact in regulating enterocyte gene transcription. J Gastrointest Surg. 5(1):49–55. DOI: 10.1016/S1091-255X(01)80013-5. PMID: 11309648.

32. Daher R, Yazbeck T, Jaoude JB, Abboud B. 2009; Consequences of dysthyroidism on the digestive tract and viscera. World J Gastroenterol. 15(23):2834–8. DOI: 10.3748/wjg.15.2834. PMID: 19533804. PMCID: PMC2699000.

33. Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK. 2010; Host-bacterial symbiosis in health and disease. Adv Immunol. 107:243–74. DOI: 10.1016/B978-0-12-381300-8.00008-3. PMID: 21034976. PMCID: PMC3152488.

34. Macpherson AJ, Harris NL. 2004; Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 4(6):478–85. DOI: 10.1038/nri1373. PMID: 15173836.

35. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005; An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 122(1):107–18. DOI: 10.1016/j.cell.2005.05.007. PMID: 16009137.

36. Sefik E, Geva-Zatorsky N, Oh S, Konnikova L, Zemmour D, McGuire AM, et al. 2015; MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(＋) regulatory T cells. Science. 349(6251):993–7. DOI: 10.1126/science.aaa9420. PMID: 26272906. PMCID: PMC4700932.

37. Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, Zhu Q, et al. 2008; Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity. 29(4):637–49. DOI: 10.1016/j.immuni.2008.08.009. PMID: 18835196. PMCID: PMC2712925.

38. Yurkovetskiy LA, Pickard JM, Chervonsky AV. 2015; Microbiota and autoimmunity: exploring new avenues. Cell Host Microbe. 17(5):548–52. DOI: 10.1016/j.chom.2015.04.010. PMID: 25974297. PMCID: PMC4535992.

39. Moon C, Baldridge MT, Wallace MA, D CA, Burnham , Virgin HW, et al. 2015; Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation. Nature. 521(7550):90–3. DOI: 10.1038/nature14139. PMID: 25686606. PMCID: PMC4425643.

40. Sidhu M, van der Poorten D. 2017; The gut microbiome. Aust Fam Physician. 46(4):206–11. PMID: 28376573.

41. Marino M, Latrofa F, Menconi F, Chiovato L, Vitti P. 2015; Role of genetic and non-genetic factors in the etiology of Graves' disease. J Endocrinol Invest. 38(3):283–94. DOI: 10.1007/s40618-014-0214-2. PMID: 25421156.

42. Hargreaves CE, Grasso M, Hampe CS, Stenkova A, Atkinson S, Joshua GW, et al. 2013; Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease. J Immunol. 190(11):5373–81. DOI: 10.4049/jimmunol.1203412. PMID: 23630351.

43. Wang Z, Zhang Q, Lu J, Jiang F, Zhang H, Gao L, et al. 2010; Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves' disease and determination of its epitope using mass spectrometry and bioinformatics tools. J Clin Endocrinol Metab. 95(8):4012–20. DOI: 10.1210/jc.2009-2184. PMID: 20484489.

44. Zimmer J, Lange B, Frick JS, Sauer H, Zimmermann K, Schwiertz A, et al. 2012; A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr. 66(1):53–60. DOI: 10.1038/ejcn.2011.141. PMID: 21811294.

45. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. 2010; Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 107(33):14691–6. DOI: 10.1073/pnas.1005963107. PMID: 20679230. PMCID: PMC2930426.

46. Lyte M, Vulchanova L, Brown DR. 2011; Stress at the intestinal surface: catecholamines and mucosa-bacteria interactions. Cell Tissue Res. 343(1):23–32. DOI: 10.1007/s00441-010-1050-0. PMID: 20941511.

47. Su X, Yin X, Liu Y, Yan X, Zhang S, Wang X, et al. 2020; Gut dysbiosis contributes to the imbalance of Treg and Th17 cells in Graves' disease patients by propionic acid. J Clin Endocrinol Metab. 105(11):dgaa511. DOI: 10.1210/clinem/dgaa511. PMID: 32785703.

48. Bahn RS. 2003; Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab. 88(5):1939–46. DOI: 10.1210/jc.2002-030010. PMID: 12727937.

49. Laurberg P, Berman DC, Bulow Pedersen I, Andersen S, Carle A. 2012; Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt. J Clin Endocrinol Metab. 97(7):2325–32. DOI: 10.1210/jc.2012-1275. PMID: 22518849. PMCID: PMC3387399.

50. Wang Y, Smith TJ. 2014; Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci. 55(3):1735–48. DOI: 10.1167/iovs.14-14002. PMID: 24651704. PMCID: PMC3968932.

51. Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS. 2011; A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol. 46(3):155–63. DOI: 10.1530/JME-11-0006. PMID: 21321093. PMCID: PMC3074639.

52. Wakelkamp IM, Gerding MN, Van Der Meer JW, Prummel MF, Wiersinga WM. 2000; Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol. 121(3):453–7. DOI: 10.1046/j.1365-2249.2000.01335.x. PMID: 10971510. PMCID: PMC1905733.

53. Shi TT, Xin Z, Hua L, Zhao RX, Yang YL, Wang H, et al. 2019; Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study. J Endocrinol Invest. 42(8):967–78. DOI: 10.1007/s40618-019-1010-9. PMID: 30674011.

54. Berchner-Pfannschmidt U, Moshkelgosha S, Diaz-Cano S, Edelmann B, Gortz GE, Horstmann M, et al. 2016; Comparative assessment of female mouse model of Graves' orbitopathy under different environments, accompanied by proinflammatory cytokine and T-cell responses to thyrotropin hormone receptor antigen. Endocrinology. 157(4):1673–82. DOI: 10.1210/en.2015-1829. PMID: 26872090.

55. Masetti G, Moshkelgosha S, Kohling HL, Covelli D, Banga JP, Berchner-Pfannschmidt U, et al. 2018; Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease. Microbiome. 6(1):97. DOI: 10.1186/s40168-018-0478-4. PMID: 29801507. PMCID: PMC5970527.

56. Moshkelgosha S, Verhasselt HL, Masetti G, Covelli D, Biscarini F, Horstmann M, et al. 2021; Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease. Microbiome. 9(1):45. DOI: 10.1186/s40168-020-00952-4. PMID: 33593429. PMCID: PMC7888139.

57. Derrien M, Van Baarlen P, Hooiveld G, Norin E, Muller M, de Vos WM. 2011; Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol. 2:166. DOI: 10.3389/fmicb.2011.00166. PMID: 21904534. PMCID: PMC3153965.

58. Shi TT, Xin Z, Hua L, Wang H, Zhao RX, Yang YL, et al. 2021; Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy. J Endocrinol Invest. 44(2):297–310. DOI: 10.1007/s40618-020-01298-2. PMID: 32449092.

59. Kim YA, Cho SW, Choi HS, Moon S, Moon JH, Kim KW, et al. 2017; The second antithyroid drug treatment is effective in relapsed Graves' disease patients: a median 11-year follow-up study. Thyroid. 27(4):491–6. DOI: 10.1089/thy.2016.0056. PMID: 28001121.

60. Penhale WJ, Young PR. 1988; The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. Clin Exp Immunol. 72(2):288–92. PMID: 2970354. PMCID: PMC1541533.

61. Lauritano EC, Bilotta AL, Gabrielli M, Scarpellini E, Lupascu A, Laginestra A, et al. 2007; Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 92(11):4180–4. DOI: 10.1210/jc.2007-0606. PMID: 17698907.

62. Sasso FC, Carbonara O, Torella R, Mezzogiorno A, Esposito V, Demagistris L, et al. 2004; Ultrastructural changes in enterocytes in subjects with Hashimoto's thyroiditis. Gut. 53(12):1878–80. DOI: 10.1136/gut.2004.047498. PMID: 15542532. PMCID: PMC1774342.

63. Mu Q, Kirby J, Reilly CM, Luo XM. 2017; Leaky gut as a danger signal for autoimmune diseases. Front Immunol. 8:598. DOI: 10.3389/fimmu.2017.00598. PMID: 28588585. PMCID: PMC5440529.

64. Benvenga S, Bartolone L, Pappalardo MA, Russo A, Lapa D, Giorgianni G, et al. 2008; Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 18(3):293–301. DOI: 10.1089/thy.2007.0222. PMID: 18341376.

65. Ianiro G, Mangiola F, Di Rienzo TA, Bibbo S, Franceschi F, Greco AV, et al. 2014; Levothyroxine absorption in health and disease, and new therapeutic perspectives. Eur Rev Med Pharmacol Sci. 18(4):451–6. PMID: 24610609.

66. Kuiper GG, Kester MH, Peeters RP, Visser TJ. 2005; Biochemical mechanisms of thyroid hormone deiodination. Thyroid. 15(8):787–98. DOI: 10.1089/thy.2005.15.787. PMID: 16131322.

67. Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. 2014; Role of the microbiome in energy regulation and metabolism. Gastroenterology. 146(6):1525–33. DOI: 10.1053/j.gastro.2014.02.008. PMID: 24560870.

68. Virili C, Bassotti G, Santaguida MG, Iuorio R, Del Duca SC, Mercuri V, et al. 2012; Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab. 97(3):E419–22. DOI: 10.1210/jc.2011-1851. PMID: 22238404.

69. Spaggiari G, Brigante G, De Vincentis S, Cattini U, Roli L, De Santis MC, et al. 2017; Probiotics ingestion does not directly affect thyroid hormonal parameters in hypothyroid patients on levothyroxine treatment. Front Endocrinol (Lausanne). 8:316. DOI: 10.3389/fendo.2017.00316. PMID: 29184537. PMCID: PMC5694461.

70. Hatakeyama M. 2017; Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 93(4):196–219. DOI: 10.2183/pjab.93.013. PMID: 28413197. PMCID: PMC5489429.

71. Lara-Tejero M, Galan JE. 2000; A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science. 290(5490):354–7. DOI: 10.1126/science.290.5490.354. PMID: 11030657.

72. Gloux K, Berteau O, El Oumami H, Beguet F, Leclerc M, Dore J. 2011; A metagenomic beta-glucuronidase uncovers a core adaptive function of the human intestinal microbiome. Proc Natl Acad Sci U S A. 108 Suppl 1:4539–46. DOI: 10.1073/pnas.1000066107. PMID: 20615998. PMCID: PMC3063586.

73. Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst. 2016; 108(8):DOI: 10.1093/jnci/djw029. PMID: 27107051. PMCID: PMC5017946.

74. Jan G, Belzacq AS, Haouzi D, Rouault A, Metivier D, Kroemer G, et al. 2002; Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ. 9(2):179–88. DOI: 10.1038/sj.cdd.4400935. PMID: 11840168.

75. Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, et al. 2007; Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8＋ T cells via TLR4 signaling. J Clin Invest. 117(8):2197–204. DOI: 10.1172/JCI32205. PMID: 17657310. PMCID: PMC1924500.

76. Konishi H, Fujiya M, Tanaka H, Ueno N, Moriichi K, Sasajima J, et al. 2016; Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat Commun. 7:12365. DOI: 10.1038/ncomms12365. PMID: 27507542. PMCID: PMC4987524.

77. Vought RL, Brown FA, Sibinovic KH, McDaniel EG. 1972; Effect of changing intestinal bacterial flora on thyroid function in the rat. Horm Metab Res. 4(1):43–7. DOI: 10.1055/s-0028-1094095. PMID: 4110893.

78. Feng J, Zhao F, Sun J, Lin B, Zhao L, Liu Y, et al. 2019; Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients. Int J Cancer. 144(11):2728–45. DOI: 10.1002/ijc.32007. PMID: 30565661.

79. Shen CT, Zhang Y, Liu YM, Yin S, Zhang XY, Wei WJ, et al. 2017; A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma. Clin Endocrinol (Oxf). 87(6):844–52. DOI: 10.1111/cen.13437. PMID: 28755525.

80. Guo L, Wang C, Chi C, Wang X, Liu S, Zhao W, et al. 2015; Exhaled breath volatile biomarker analysis for thyroid cancer. Transl Res. 166(2):188–95. DOI: 10.1016/j.trsl.2015.01.005. PMID: 25666355.